HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ME1036

structure in first source

Also Known As:

CP5609

Networked: 3 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amides: 2428
  - Lactams: 2198
    - beta-Lactams: 2386
      - Carbapenems: 4837
        ME1036: 3
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - beta-Lactams: 2386
      - Carbapenems: 4837
        ME1036: 3

Experts

1.	Biek, Don: 1 article (07/2009)
2.	Janes, Regina: 1 article (07/2009)
3.	Morrissey, Ian: 1 article (07/2009)
4.	Izumikawa, Koichi: 1 article (11/2008)
5.	Kakeya, Hiroshi: 1 article (11/2008)
6.	Kamihira, Shimeru: 1 article (11/2008)
7.	Kohno, Shigeru: 1 article (11/2008)
8.	Kurihara, Shintaro: 1 article (11/2008)
9.	Morinaga, Yoshitomo: 1 article (11/2008)
10.	Nakamura, Shigeki: 1 article (11/2008)

Related Diseases

1.	Endocarditis 08/01/2005 - "Compared with vancomycin, ME1036 reduced the bacterial counts in the vegetations at a lower dosage or over a shorter period of administration when it was used for the treatment of MRSA endocarditis." 08/01/2005 - "Therapeutic effect of ME1036 on endocarditis experimentally induced by methicillin-resistant Staphylococcus aureus." 08/01/2005 - "The efficacy of ME1036, a novel parenteral carbapenem, was compared with that of vancomycin by using a rabbit model of methicillin-resistant Staphylococcus aureus (MRSA) endocarditis. "
2.	Pneumonia (Pneumonitis) 07/01/2009 - "ME1036, a novel carbapenem, with enhanced activity against clinical isolates causing bacteraemic community-acquired pneumonia."
3.	Infections 11/01/2008 - "After 24h of infection, mice were treated twice daily for 7 days with 200mg/kg/day vancomycin (VCM) or ME1036. "

Related Drugs and Biologics

1.	Carbapenems (Carbapenem Antibiotics)
2.	Vancomycin
3.	Therapeutic Uses